CRL vs SYF · rev $2.00B vs rev $11.19B
Charles River Laboratories (CRL) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
SYF (SYF) common stock.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
CRL currently screens at market cap $7.78B. SYF currently screens at market cap $0.
Not investment advice. Open the CRL and SYF stock pages for the full models.
Not investment advice.